HWAM
RGNX icon

Hennion & Walsh Asset Management’s Regenxbio RGNX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-88,385
Closed -$741K – 1002
2026
Q1 		$741K Sell
88,385
-5,532
-6% -$58.1K 0.02% 587
2025
Q4 		$1.35M Sell
93,917
-47,809
-34% -$596K 0.05% 445
2025
Q3 		$1.37M Sell
141,726
-12,766
-8% -$113K 0.05% 433
2025
Q2 		$1.27M Sell
154,492
-4,891
-3% -$40.9K 0.05% 435
2025
Q1 		$1.14M Sell
159,383
-5,346
-3% -$39.8K 0.05% 444
2024
Q4 		$1.27M Buy
164,729
+13,014
+9% +$122K 0.06% 407
2024
Q3 		$1.59M Buy
151,715
+17,525
+13% +$214K 0.07% 341
2024
Q2 		$1.57M Buy
134,190
+27,906
+26% +$434K 0.08% 311
2024
Q1 		$2.24M Buy
106,284
+32,584
+44% +$580K 0.12% 235
2023
Q4 		$1.32M Buy
73,700
+13,336
+22% +$235K 0.08% 339
2023
Q3 		$994K Sell
60,364
-5,425
-8% -$98.3K 0.06% 359
2023
Q2 		$1.31M Sell
65,789
-36,474
-36% -$703K 0.08% 316
2023
Q1 		$1.93M Sell
102,263
-3,012
-3% -$66.6K 0.12% 211
2022
Q4 		$2.39M Buy
105,275
+11,394
+12% +$258K 0.15% 176
2022
Q3 		$2.48M Buy
93,881
+4,387
+5% +$130K 0.16% 160
2022
Q2 		$2.21M Buy
89,494
+21,487
+32% +$537K 0.14% 186
2022
Q1 		$2.26M Buy
68,007
+14,260
+27% +$396K 0.12% 207
2021
Q4 		$1.76M Buy
53,747
+22,859
+74% +$778K 0.09% 254
2021
Q3 		$1.29M Buy
30,888
+10,576
+52% +$381K 0.07% 303
2021
Q2 		$789K Buy
+20,312
New +$726K 0.04% 417

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Hennion & Walsh Asset Management's RGNX Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 88,385 shares — an estimated $741K sold.

Hennion & Walsh Asset Management first reported a position in RGNX in Q2 2021 and held it in 20 quarters. The position peaked at $2.48M in Q3 2022. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 88,385 Regenxbio shares in Q2 2026, an estimated $741K.
  • Hennion & Walsh Asset Management first reported a position in Regenxbio in Q2 2021 and held it in 20 quarters.
  • Hennion & Walsh Asset Management's Regenxbio position peaked at $2.48M in Q3 2022.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.